logo

Emcure Pharmaceuticals Ltd. Financials

15:59 May 23

Emcure Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1284.40
+116.70 (+9.99%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Emcure Pharmaceuticals Ltd. Financials

Emcure Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1284.40
+116.70 (+9.99%)
15:59 May 23
Quality
image/svg+xml

91/100
High Financial Strength

Valuation
image/svg+xml

34/100
Mid Valuation

Technical

52/100
Technically Neutral

Strength

8

Weakness

6

Opportunity

1

Threats

1

15.32 %

ROE %

8.27 %

ROA %

35.96

EPS

234.65

BVPS

8.62 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
5855.39 5985.81 6658.25 7896
Operating Expenses +
4525.47 4804.63 5428.52 6421.62
Raw Material
2378.55 2193.83 2665.61 3410.14
Increase Decrease in Cost
-145.4 66.69 -190.19 -263.53
Other Manufacturing Expense
0 0 0 0
Employee Cost
1011.82 1117.33 1292.08 1446.29
Miscellaneous Expenses
3445.4 3521.26 4325.98 5595.2
Operating Profit
1329.92 1181.18 1229.73 1474.38
Other Income
63.47 45.9 56.99 67.26
Depreciation
244.86 260.12 312.41 384.13
Interest
175.98 213.61 237.15 175.78
Profit before tax and exceptio..
972.55 753.36 737.16 981.73
Exceptional Items
0 -6.15 -9.93 -10.38
PBT
972.55 747.22 727.23 971.35
Provision for Taxation
269.99 185.37 199.65 263.88
Net Profit
702.56 561.84 527.58 707.47
NET Profit after MI
662.2 532.02 498.18 681.33
EPS
36.62 29.42 27.54 36.43
Operating Profit Margin (%)
22.71 19.73 18.47 18.67
Net Profit Margin (%)
11.31 8.89 7.48 8.63

Emcure Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24
Promoter 77.90 77.90
FII 3.10 3.00
MF 2.70 3.10
Public 15.60 15.20
Others 0.00 0.00
Others 0.70 0.80
Shareholder Shares Holding %
Research 360 logo

Download Our App On: